BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33330873)

  • 1. SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential.
    Vithani N; Ward MD; Zimmerman MI; Novak B; Borowsky JH; Singh S; Bowman GR
    bioRxiv; 2020 Dec; ():. PubMed ID: 33330873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential.
    Vithani N; Ward MD; Zimmerman MI; Novak B; Borowsky JH; Singh S; Bowman GR
    Biophys J; 2021 Jul; 120(14):2880-2889. PubMed ID: 33794150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis.
    Wang Y; Sun Y; Wu A; Xu S; Pan R; Zeng C; Jin X; Ge X; Shi Z; Ahola T; Chen Y; Guo D
    J Virol; 2015 Aug; 89(16):8416-27. PubMed ID: 26041293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional insights into the 2'-O-methyltransferase of SARS-CoV-2.
    Deng J; Gong F; Li Y; Tan X; Liu X; Yang S; Chen X; Wang H; Liu Q; Shen C; Zhou L; Chen Y
    Virol Sin; 2024 Jul; ():. PubMed ID: 38969340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Investigation of Structural Dynamics of SARS-CoV-2 Methyltransferase-Stimulatory Factor Heterodimer nsp16/nsp10 Bound to the Cofactor SAM.
    Sk MF; Jonniya NA; Roy R; Poddar S; Kar P
    Front Mol Biosci; 2020; 7():590165. PubMed ID: 33330626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of the Methyl Donor
    Aouadi W; Blanjoie A; Vasseur JJ; Debart F; Canard B; Decroly E
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.
    Ke M; Chen Y; Wu A; Sun Y; Su C; Wu H; Jin X; Tao J; Wang Y; Ma X; Pan JA; Guo D
    Virus Res; 2012 Aug; 167(2):322-8. PubMed ID: 22659295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a Druggable, Cryptic Pocket in SARS-CoV-2 nsp16 Using Allosteric Inhibitors.
    Inniss NL; Kozic J; Li F; Rosas-Lemus M; Minasov G; Rybáček J; Zhu Y; Pohl R; Shuvalova L; Rulíšek L; Brunzelle JS; Bednárová L; Štefek M; Kormaník JM; Andris E; Šebestík J; Li ASM; Brown PJ; Schmitz U; Saikatendu K; Chang E; Nencka R; Vedadi M; Satchell KJF
    ACS Infect Dis; 2023 Oct; 9(10):1918-1931. PubMed ID: 37728236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of critical protein-protein interactions of SARS-CoV-2 capping and proofreading molecular machineries towards designing dual target inhibitory peptides.
    Arabi-Jeshvaghani F; Javadi-Zarnaghi F; Ganjalikhany MR
    Sci Rep; 2023 Jan; 13(1):350. PubMed ID: 36611052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.
    Chen Y; Su C; Ke M; Jin X; Xu L; Zhang Z; Wu A; Sun Y; Yang Z; Tien P; Ahola T; Liang Y; Liu X; Guo D
    PLoS Pathog; 2011 Oct; 7(10):e1002294. PubMed ID: 22022266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16.
    Klima M; Khalili Yazdi A; Li F; Chau I; Hajian T; Bolotokova A; Kaniskan HÜ; Han Y; Wang K; Li D; Luo M; Jin J; Boura E; Vedadi M
    Protein Sci; 2022 Sep; 31(9):e4395. PubMed ID: 36040262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SS148 and WZ16 inhibit the activities of nsp10-nsp16 complexes from all seven human pathogenic coronaviruses.
    Li F; Ghiabi P; Hajian T; Klima M; Li ASM; Khalili Yazdi A; Chau I; Loppnau P; Kutera M; Seitova A; Bolotokova A; Hutchinson A; Perveen S; Boura E; Vedadi M
    Biochim Biophys Acta Gen Subj; 2023 Apr; 1867(4):130319. PubMed ID: 36764586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamic simulations reveal anti-SARS-CoV-2 activity of mitocurcumin by potentially blocking innate immune evasion proteins NSP3 and NSP16.
    Pal D; Checker R; Kutala VK; Sandur SK
    Mol Divers; 2023 Apr; 27(2):635-649. PubMed ID: 35538380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSP16 2'-O-MTase in Coronavirus Pathogenesis: Possible Prevention and Treatments Strategies.
    Chang LJ; Chen TH
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33804957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex.
    Khalili Yazdi A; Li F; Devkota K; Perveen S; Ghiabi P; Hajian T; Bolotokova A; Vedadi M
    SLAS Discov; 2021 Jul; 26(6):757-765. PubMed ID: 33874769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19.
    Perveen S; Khalili Yazdi A; Devkota K; Li F; Ghiabi P; Hajian T; Loppnau P; Bolotokova A; Vedadi M
    SLAS Discov; 2021 Jun; 26(5):620-627. PubMed ID: 33423577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Interactions of Zyesami with the SARS-CoV-2 nsp10/nsp16 Protein Complex.
    Alnomasy SF; Alotaibi BS; Aldosari ZM; Mujamammi AH; Alzamami A; Anand P; Akhter Y; Khan FR; Hasan MR
    Comb Chem High Throughput Screen; 2023; 26(6):1196-1203. PubMed ID: 35975856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study.
    Aldahham BJM; Al-Khafaji K; Saleh MY; Abdelhakem AM; Alanazi AM; Islam MA
    J Biomol Struct Dyn; 2022 Jun; 40(9):3899-3906. PubMed ID: 33252031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16.
    Wang H; Rizvi SRA; Dong D; Lou J; Wang Q; Sopipong W; Su Y; Najar F; Agarwal PK; Kozielski F; Haider S
    Elife; 2023 Dec; 12():. PubMed ID: 38127066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.
    Mohammad A; Alshawaf E; Marafie SK; Abu-Farha M; Al-Mulla F; Abubaker J
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.